# Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

> **NCT04301765** · PHASE2 · RECRUITING · sponsor: **Seattle Institute for Biomedical and Clinical Research** · enrollment: 230 (estimated)

## Conditions studied

- Hypogonadism, Male
- Cancer
- Fatigue

## Interventions

- **DRUG:** testosterone 1.62% gel
- **OTHER:** placebo gel

## Key facts

- **NCT ID:** NCT04301765
- **Lead sponsor:** Seattle Institute for Biomedical and Clinical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-12
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04301765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04301765, "Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04301765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*